Nuwellis Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Nuwellis Inc trades at $1.42 (market cap $542.80K), while Invesco WilderHill Clean Energy ETF trades at $34.81. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | PBW | |
|---|---|---|
Market Cap | $542.80K | — |
Sector | Technology | Sector/Thematic |
52-Week High | $220.50 | $46.99 |
52-Week Low | $1.42 | $24.14 |
Enterprise Value | -$1.27M | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.
Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.
PBW trades at $34.93, up 0.92% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF benefits from clean energy tailwinds, including rising global investment and energy security concerns, yet lacks disclosed fundamental ratios. Recent news highlights volatility linked to interest rate movements and sector rotations.
Outlook is mixed: clean energy demand offers growth potential, but sensitivity to Treasury yields and tech sell-offs poses risks. Investors face upside from policy support offset by macroeconomic headwinds and valuation uncertainties due to missing financial data.
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →